Although the primary purpose of the CRISPR screens was to detect resistance genes, whether, through overexpression or silencing, the same data can be analysed for genes that when silenced have the opposite effect – enhancing the effect of osimertinib or gefitinib in EGFR mutant lung cancer cells. This evidence concerns the gene EGFR and lung cancer.